{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:08:13Z","timestamp":1790730493271,"version":"4.1.0"},"publisher-location":"New York, NY","reference-count":88,"publisher":"Springer US","isbn-type":[{"value":"9781071641996","type":"print"},{"value":"9781071642009","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4200-9_7","type":"book-chapter","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:07:24Z","timestamp":1731650844000},"page":"111-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Psycho-Neuro-EndocrinE-Immunology Therapy of Cancer, Autoimmunity, Geriatric Disorders, Covid-19, and Hypertension"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-1350","authenticated-orcid":false,"given":"Paolo","family":"Lissoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rovelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusy","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Monzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sassola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Di Fede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Simoes-de-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgiliu Gheorghe","family":"Vlaescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Diego","family":"Cardinali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"7_CR1","first-page":"1","volume":"4","author":"KW Starr","year":"1970","unstructured":"Starr KW (1970) Growth and new growth: environmental carcinogens in the process of human ontogeny. Prog Clin Cancer 4:1\u201313","journal-title":"Prog Clin Cancer"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.7233204","volume":"212","author":"V Riley","year":"1981","unstructured":"Riley V (1981) Psychoneuroendocrine influences on immunocompetence and neoplasia. Science 212:1100\u20131109","journal-title":"Science"},{"key":"7_CR3","first-page":"79","volume":"10","author":"DR Rubinow","year":"1990","unstructured":"Rubinow DR (1990) Brain, behaviour and immunity: an interactive system. J Natl Cancer Inst Monogr 10:79\u201382","journal-title":"J Natl Cancer Inst Monogr"},{"key":"7_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0196-9781(83)90010-4","volume":"4","author":"JW Lewis","year":"1983","unstructured":"Lewis JW, Shavit Y, Terman GV (1983) Apparent involvement of opiod peptides in stress-induced enhancement of tumor growth. Peptides 4:635\u2013638","journal-title":"Peptides"},{"key":"7_CR5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000127128","volume":"64","author":"P Sacerdote","year":"2014","unstructured":"Sacerdote P, Manfredi B, Mantegazza P et al (2014) Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Neuroendocrinology 64:274\u2013279","journal-title":"Neuroendocrinology"},{"key":"7_CR6","first-page":"14","volume":"25","author":"F Grotenhermen","year":"2004","unstructured":"Grotenhermen F (2004) Pharmacology of cannabinoids. Neuroendocrinol Lett 25:14\u201323","journal-title":"Neuroendocrinol Lett"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0140-6736(75)92390-9","volume":"I","author":"RS Buswell","year":"1975","unstructured":"Buswell RS (1975) The pineal and neoplasia. Lancet I:34\u201335","journal-title":"Lancet"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1056\/NEJM199701163360306","volume":"336","author":"A Brzezinski","year":"1997","unstructured":"Brzezinski A (1997) Melatonin in humans. N Engl J Med 336:186\u2013195","journal-title":"N Engl J Med"},{"key":"7_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.1993.tb00478.x","volume":"14","author":"GJM Maestroni","year":"1993","unstructured":"Maestroni GJM (1993) Theimmunoneuroendocrine role of melatonin. J Pineal Res 14:1\u201310","journal-title":"J Pineal Res"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-079X.2004.00165.x","volume":"37","author":"RJ Reiter","year":"2004","unstructured":"Reiter RJ (2004) Mechanisms of cancer inhibition by melatonin. J Pineal Res 37:213\u2013214","journal-title":"J Pineal Res"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1084\/jem.155.6.1823","volume":"155","author":"EA Grimm","year":"1982","unstructured":"Grimm EA, Mazumder A, Zhang HZ et al (1982) Lymphokine-activated killer cell phenomenon. J Exp Med 155:1823\u20131841","journal-title":"J Exp Med"},{"key":"7_CR12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/bjc.1995.130","volume":"71","author":"RE Banks","year":"1995","unstructured":"Banks RE, Patel RM, Selby PJ (1995) Interleukin-12: a new clinical player in cytokine therapy. Br J Cancer 71:655\u2013659","journal-title":"Br J Cancer"},{"key":"7_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/0008-5472.CAN-07-3086","volume":"68","author":"X Kong","year":"2008","unstructured":"Kong X, Wang X, Xu W et al (2008) Natriuretic peptide receptor A as a novel anticancer target. Cancer Res 68:249\u2013256","journal-title":"Cancer Res"},{"key":"7_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.29245\/2689-9981\/2020\/1.1155","volume":"3","author":"P Lissoni","year":"2020","unstructured":"Lissoni P, Messina G, Pelizzoni F et al (2020) The fascination of cytokineimmunological science. J Infectiol 3:18\u201328","journal-title":"J Infectiol"},{"key":"7_CR15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-079X.1993.tb00481.x","volume":"14","author":"SF Sze","year":"1993","unstructured":"Sze SF, Ng TB, Liu KW (1993) Antiproliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 14:27\u201322","journal-title":"J Pineal Res"},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/138161212799436593","volume":"18","author":"LS Capettini","year":"2012","unstructured":"Capettini LS, Montecucco F, Mach F et al (2012) Role of renin-angiotensin system in inflammation, immunity, and aging. Curr Pharm Des 18:963\u2013970","journal-title":"Curr Pharm Des"},{"key":"7_CR17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"AC Simoes-e-Silva","year":"2013","unstructured":"Simoes-e-Silva AC, Silveira KD, Ferreira AJ et al (2013) ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 169:477\u2013492","journal-title":"Br J Pharmacol"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","volume":"98","author":"RAS Santos","year":"2018","unstructured":"Santos RAS, Sampaio WO, Alzamora AC et al (2018) The ACE2\/angiotensin-(1-7)\/Mas receptor axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev 98:505\u2013553","journal-title":"Physiol Rev"},{"key":"7_CR19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7827-13-5","volume":"13","author":"KB Brosnihan","year":"2015","unstructured":"Brosnihan KB, Pulgar VM, Gallagher PE et al (2015) Local uterine Ang-(1-7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudo-pregnant rats. Reprod Biol Endocrinol 13:5\u20138","journal-title":"Reprod Biol Endocrinol"},{"key":"7_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/ORR.1000126","volume":"2","author":"P Lissoni","year":"2019","unstructured":"Lissoni P, Rovelli F, Messina G et al (2019) A review on the neuroendocrine regulation of cytokine secretion: possible modulation of the cytokine network by the pineal hormone melatonin and cannabidiol. Oncol Res Rev 2:1\u20134","journal-title":"Oncol Res Rev"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/157489012801227210","volume":"7","author":"M Jankowski","year":"2012","unstructured":"Jankowski M, Gonzales-Reyes A, Noiseaux N et al (2012) Oxytocin in the heart regeneration. Recent Pat Cardiovasc Drug Discov 7:81\u201387","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1523\/JNEUROSCI.1223-09.2009","volume":"29","author":"E Ganon-Elazar","year":"2009","unstructured":"Ganon-Elazar E, Akirav I (2009) Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and excitation of inhibitory avoidance. J Neurosci 29:11078\u201311088","journal-title":"J Neurosci"},{"key":"7_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000124168","volume":"41","author":"RJ Bicknell","year":"1985","unstructured":"Bicknell RJ, Chapman C, Leng G (1985) Effects of opioid agonists and antagonists on oxytocin and vasopressin release in vitro. Neuroendocrinology 41:142\u2013148","journal-title":"Neuroendocrinology"},{"key":"7_CR24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1126\/science.abj2674","volume":"377","author":"Y Xu","year":"2022","unstructured":"Xu Y, Yan J, Tao Y et al (2022) Pituitary hormone alpha-MSH promotes tumor-induced myelopoiesis and immunosuppression. Science 377:1085\u20131091","journal-title":"Science"},{"key":"7_CR25","doi-asserted-by":"crossref","first-page":"R577","DOI":"10.1152\/ajpregu.00667.2005","volume":"290","author":"N Sabatier","year":"2006","unstructured":"Sabatier N, Leng G (2006) Presynaptic actions of endocannabinoid mediate alpha-MSH-induced inhibition of oxytocin cells. Am J Physiol Regul Integr Comp Physiol 290:R577\u2013R584","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"7_CR26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.neuroimage.2015.09.066","volume":"124","author":"J Levy","year":"2016","unstructured":"Levy J, Golstein A, Zagoory-Sharon O et al (2016) Oxytocin selectively modulates brain response to stimuli probing social synchrony. NeuroImage 124:923\u2013930","journal-title":"NeuroImage"},{"key":"7_CR27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.peptides.2012.08.005","volume":"38","author":"R Russo","year":"2012","unstructured":"Russo R, D\u2019Agostino G, Mattace Raso G et al (2012) Central administration of oxytocinreduceshyperalgesia in mice: implication for cannabinoid and opioid systems. Peptides 38:81\u201388","journal-title":"Peptides"},{"key":"7_CR28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2007-1012235","volume":"18","author":"P Lissoni","year":"1986","unstructured":"Lissoni P, Resentini M, Mauri R et al (1986) Effects of tetrahydrocannabinol on melatoninsecretion in man. Horm Metab Res 18:77\u201378","journal-title":"Horm Metab Res"},{"key":"7_CR29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0741-8329(88)90075-4","volume":"5","author":"MD Schechter","year":"1988","unstructured":"Schechter MD, Signs SA (1988) Interaction of ethanol and tetrahydro-beta-carboline (THBC) in a discriminative task. Alcohol 5:331\u2013335","journal-title":"Alcohol"},{"key":"7_CR30","unstructured":"Lissoni P, Rovelli F, Messina G et al (2019) A preliminary study on the correlation between IL-6 and IL-17 secretions in human systemic diseases: possible existence of two different origins of the inflammatory response. Clin Oncol Res CORJ-100004"},{"key":"7_CR31","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.4049\/jimmunol.0901017","volume":"183","author":"G Murugaiyan","year":"2009","unstructured":"Murugaiyan G, Saha B (2009) Protumor vs antitumor functions of IL-17. J Immunol 183:4169\u20134175","journal-title":"J Immunol"},{"key":"7_CR32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/156800906778742460","volume":"6","author":"EF Saunier","year":"2006","unstructured":"Saunier EF, Akhurst RT (2006) GF-beta inhibition for cancer therapy. Curr Cancer Drug Targets 6:565\u2013578","journal-title":"Curr Cancer Drug Targets"},{"key":"7_CR33","first-page":"31","volume":"2","author":"P Lissoni","year":"2018","unstructured":"Lissoni P, Messina G, Cenaj V et al (2018) The role of IL-17 secretion in mediating the influence of stress on 2 and other human systemic diseases. MOJ Lymphol Phlebol 2:31\u201334","journal-title":"MOJ Lymphol Phlebol"},{"key":"7_CR34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1189\/jlb.0603272","volume":"74","author":"TR Malek","year":"2003","unstructured":"Malek TR (2003) The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol 74:961\u2013965","journal-title":"J Leukoc Biol"},{"key":"7_CR35","first-page":"7876","volume":"3","author":"L Gu","year":"2016","unstructured":"Gu L, Li H, Chen L et al (2016) Prognostic role of lymphocyte-to-monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget 3:7876\u20137881","journal-title":"Oncotarget"},{"key":"7_CR36","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1007\/s10067-017-3815-2","volume":"36","author":"J Du","year":"2017","unstructured":"Du J, Chen S, Shi J et al (2017) The association between the lymphocyte-to-monocyte ratio and disease activity in rheumatoid arthritis. Clin Rheumatol 36:2689\u20132695","journal-title":"Clin Rheumatol"},{"key":"7_CR37","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani A, Allavena P, Sica A et al (2008) Cancer-related in inflammation. Nature 454:436\u2013444","journal-title":"Nature"},{"key":"7_CR38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/1744666X.2017.1245146","volume":"13","author":"P Lissoni","year":"2017","unstructured":"Lissoni P (2017) Therapy implications of interleukin-2 in cancer. Exp Rev Clin Immunol 13:491\u2013498","journal-title":"Exp Rev Clin Immunol"},{"key":"7_CR39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","volume":"22","author":"J He","year":"2016","unstructured":"He J, Zhang X, Zhanguo L (2016) Low-dose interleukin-2 treatment selectively modulates CD4+ YT cell subsets in patients with systemic lupus erythematosus. Nat Med 22:991\u2013993","journal-title":"Nat Med"},{"key":"7_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/0929866527666191230103739","volume":"27","author":"VY Ribeiro","year":"2020","unstructured":"Ribeiro VY, Cruz de Souza L, Simoes-e-Silva AC (2020) Renin-angiotensin system and Alzheimer\u2019s disease pathophysiology: from the potential interactions to therapeutic perspectives. Protein Peptide Lett 27:1\u201326","journal-title":"Protein Peptide Lett"},{"key":"7_CR41","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.autrev.2017.07.009","volume":"16","author":"M Robert","year":"2027","unstructured":"Robert M, Miossec P (2027) Effect of interleukin-17 on the cardiovascular system. Autoimmun Rev 16:984\u2013991","journal-title":"Autoimmun Rev"},{"key":"7_CR42","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","volume":"55","author":"MS Madhur","year":"2010","unstructured":"Madhur MS, Lob HE, McCann LA et al (2010) Interleukin-17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55:500\u2013507","journal-title":"Hypertension"},{"key":"7_CR43","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.179.3.1423","volume":"179","author":"I Kryczek","year":"2007","unstructured":"Kryczek I, Wei S, Vatan L et al (2007) Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool subverts IL-2-mediated suppression. J Immunol 179:1423\u20131426","journal-title":"J Immunol"},{"key":"7_CR44","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S et al (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11:875\u2013879","journal-title":"Nat Med"},{"key":"7_CR45","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejim.2020.04.037","volume":"76","author":"P Verdecchia","year":"2020","unstructured":"Verdecchia P, Cavallini C, Spanevello A et al (2020) The pivotal link between ACE2 deficiency and Sars-CoV-2 infection. Eur J Int Med 76:14\u201320","journal-title":"Eur J Int Med"},{"key":"7_CR46","first-page":"16","volume":"4","author":"P Lissoni","year":"2023","unstructured":"Lissoni P, Aymerich T, Pandolfi L et al (2023) A study of angiotensin 1-7 secretion in cancer patients and its correlation to IL-17 production and the immune status of patients. Clin Res Hematol 4:16\u201320","journal-title":"Clin Res Hematol"},{"key":"7_CR47","first-page":"264","volume":"467","author":"C Bartsch","year":"1999","unstructured":"Bartsch C, Bartsch H (1999) Melatonin in cancer patients and in tumor-bearing animals. Adv Exp Med Biol 467:264\u2013274","journal-title":"Adv Exp Med Biol"},{"key":"7_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113321","volume":"216","author":"S Aaghaz","year":"2021","unstructured":"Aaghaz S, Sharma K, Jain R et al (2021) Beta-carbolines as potential anticancer agents. Eur J Med Chem 216:113321","journal-title":"Eur J Med Chem"},{"key":"7_CR49","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1210\/en.2014-1980","volume":"156","author":"TK Kim","year":"2015","unstructured":"Kim TK, Lin Z, Li W, Reiter RJ et al (2015) N-acetyl-5-methoxykynuramine (AMK) is produced in the human epidermis and shows antiproliferative effects. Endocrinology 156:1630\u20131636","journal-title":"Endocrinology"},{"key":"7_CR50","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(197203)29:3<706::AID-CNCR2820290325>3.0.CO;2-A","volume":"29","author":"SI Hadjiu","year":"1972","unstructured":"Hadjiu SI, Porro RS, Lieberman PH (1972) Degeneration of the pineal gland of patients with cancer. Cancer 29:706\u2013709","journal-title":"Cancer"},{"key":"7_CR51","doi-asserted-by":"publisher","unstructured":"Campos LA, Cipolla-Neto J, Amaral FG et al (2013) The angiotensin-melatonin axis. Int J Hypertens. https:\/\/doi.org\/10.1155\/2013\/521783","DOI":"10.1155\/2013\/521783"},{"key":"7_CR52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/07357908709170112","volume":"5","author":"W Regelson","year":"1987","unstructured":"Regelson W, Pierpaoli W (1987) Melatonin: a rediscoveredantitumorhormone? Cancer Investig 5:379\u2013385","journal-title":"Cancer Investig"},{"key":"7_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31021\/ijii.20181104","volume":"1","author":"P Lissoni","year":"2018","unstructured":"Lissoni P, Messina G, Rovelli F et al (2018) Dose-dependency of antitumor effects of the pineal hormone melatonin in untreatable metastatic solid tumor patients. Int J Immunol Immunobiol 1:1\u20133","journal-title":"Int J Immunol Immunobiol"},{"key":"7_CR54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","volume":"39","author":"E Millis","year":"2005","unstructured":"Millis E, Wu P, Seely D, Guyatt G (2005) Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res 39:360\u2013366","journal-title":"J Pineal Res"},{"key":"7_CR55","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuropharm.2017.08.017","volume":"125","author":"M Celorrio","year":"2017","unstructured":"Celorrio M, Rojo-Bustamante E, Fernandez-Suarez D et al (2017) GPR55: a therapeutic target for Parkinson\u2019s disease? Neuropharmacology 125:319\u2013332","journal-title":"Neuropharmacology"},{"key":"7_CR56","first-page":"31","volume":"25","author":"EB Russo","year":"2004","unstructured":"Russo EB (2004) Clinical endocannabinoid deficiency (CECD). Neuroendocrinol Lett 25:31\u201339","journal-title":"Neuroendocrinol Lett"},{"key":"7_CR57","first-page":"1","volume":"28","author":"P Clayton","year":"2021","unstructured":"Clayton P, Subah S, Venkatesh R et al (2021) Palmitoyl-ethanol-amide: a potential alternative to cannabidiol. J Diet Suppl 28:1\u201326","journal-title":"J Diet Suppl"},{"key":"7_CR58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF01252128","volume":"19","author":"P P\u00e9vet","year":"1980","unstructured":"P\u00e9vet P, Balemans MGM, Lwegerstee WC et al (1980) Circadian rhythmicity of the activity of hydroxy-indole-O-methyltransferase (HIOMT) in the formation of melatonin and 5-methoxytryptophol in the pineal, retina and Harderian gland of the golden hamster. J Neural Transm 19:229\u2013235","journal-title":"J Neural Transm"},{"key":"7_CR59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.15761\/ORR.1000126","volume":"2","author":"P Lissoni","year":"2019","unstructured":"Lissoni P, Rovelli F, Messina G et al (2019) A review on the neuroendocrine regulation of cytokine secretion: possible modulation of the cytokine network by the pineal hormone melatonin and cannabidiol. Oncol Res Rev 2:2\u20134","journal-title":"Oncol Res Rev"},{"key":"7_CR60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01256752","volume":"52","author":"H Bartsch","year":"1981","unstructured":"Bartsch H, Bartsch C (1981) Effect of melatonin on experimental tumors under different photoperiods and times of administration. J Neural Transm 52:269\u2013279","journal-title":"J Neural Transm"},{"key":"7_CR61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","volume":"37","author":"DH Munn","year":"2016","unstructured":"Munn DH, Mellar AL (2016) IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance. Trends Immunol 37:193\u2013207","journal-title":"Trends Immunol"},{"key":"7_CR62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","volume":"119","author":"Y Mandi","year":"2012","unstructured":"Mandi Y, Vecsei L (2012) The kynurenine system and immunoregulation. J Neural Transm (Vienna) 119:197\u2013209","journal-title":"J Neural Transm (Vienna)"},{"key":"7_CR63","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1177\/1535370217693114","volume":"242","author":"J Bartosiewicz","year":"2017","unstructured":"Bartosiewicz J, Kaminski T, Pawlak K et al (2017) The activation of the kynurenine pathway in a rat model with renovascular hypertension. Exp Biol Med (Maywood) 242:750\u2013761","journal-title":"Exp Biol Med (Maywood)"},{"key":"7_CR64","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.4172\/2576-1471.1000134","volume":"2","author":"MC Chappell","year":"2017","unstructured":"Chappell MC, Al Zayadneh EM (2017) Angiotensin 1-7 and the regulation of anti-fibrotic signaling pathways. J Cell Signal 2:1234\u20131238","journal-title":"J Cell Signal"},{"key":"7_CR65","doi-asserted-by":"crossref","first-page":"14948","DOI":"10.1073\/pnas.0903958106","volume":"106","author":"M Platten","year":"2009","unstructured":"Platten M, Youssef S et al (2009) Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 106:14948\u201314953","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR66","first-page":"1","volume":"2","author":"P Lissoni","year":"2018","unstructured":"Lissoni P, Rovelli F, Brivio F et al (2018) Five-year survival with high-dose melatonin and other antitumor pineal hormones in advanced cancer patients eligible for the only palliative therapy. Res J Oncol 2:1\u20137","journal-title":"Res J Oncol"},{"key":"7_CR67","doi-asserted-by":"publisher","unstructured":"Lissoni P, Messina G, Di Fede G (2020) A short-period therapy with subcutaneous low-dose IL-2 plus high-dose melatonin to correct advanced cancer-related lymphocytopenia: possible impact on the survival time. Psychoneuroimmunol J. https:\/\/doi.org\/10.32371\/pnij\/246105","DOI":"10.32371\/pnij\/246105"},{"key":"7_CR68","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1097-0142(197001)25:1<135::AID-CNCR2820250120>3.0.CO;2-9","volume":"25","author":"A Riesco","year":"1970","unstructured":"Riesco A (1970) Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer 25:135\u2013140","journal-title":"Cancer"},{"key":"7_CR69","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","volume":"27","author":"T Korn","year":"2009","unstructured":"Korn T, Bettelli E, Oukka M et al (2009) IL-17 and Th17 cells. Annu Rev Immunol 27:485\u2013517","journal-title":"Annu Rev Immunol"},{"key":"7_CR70","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00281-009-0188-x","volume":"32","author":"K Wolk","year":"2010","unstructured":"Wolk K, Witte K, Warszawska K et al (2010) Biology of interlekin-22. Semin Immunopathol 32:17\u201331","journal-title":"Semin Immunopathol"},{"key":"7_CR71","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/eji.200535239","volume":"36","author":"MA Hoeve","year":"2006","unstructured":"Hoeve MA, Savage ND, de Boer T et al (2006) Divergent effects of IL-12 and IL-.23 on the production of IL-17 by human T cells. Eur J Immunol 36:661\u2013670","journal-title":"Eur J Immunol"},{"key":"7_CR72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1357-2725(97)00128-3","volume":"30","author":"DA Clark","year":"1998","unstructured":"Clark DA, Coker R (1998) Transforming growth factor beta (TGF-beta). Int J Biochem Cell Biol 30:293\u2013298","journal-title":"Int J Biochem Cell Biol"},{"key":"7_CR73","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajpath.2012.08.041","volume":"182","author":"J Ye","year":"2013","unstructured":"Ye J, Livergood RS, Peng G (2013) The role and the regulation of human Th17 cells in tumor immunity. Am J Pathol 182:10\u201320","journal-title":"Am J Pathol"},{"key":"7_CR74","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/BOR.0000000000000575","volume":"31","author":"J Humrich","year":"2019","unstructured":"Humrich J, Riemekasten G (2019) Low-dose interleukin-2 therapy for the treatment of systemic lupus erythematosus. Curr Opin Reumathol 31:208\u2013212","journal-title":"Curr Opin Reumathol"},{"key":"7_CR75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao V et al (2006) Reciprocal development pathways in the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235\u2013238","journal-title":"Nature"},{"key":"7_CR76","first-page":"7","volume":"4","author":"P Lissoni","year":"2022","unstructured":"Lissoni P, Tassoni S, Messina G et al (2022) Neuroimmune therapy with autoimmune diseases with the pineal hormone melatonin plus cannabidiol and its effects on auto-antibody production. Clin Res Neurol 4:7\u201310","journal-title":"Clin Res Neurol"},{"key":"7_CR77","first-page":"1","volume":"35","author":"A Lopez-Gonzales","year":"2014","unstructured":"Lopez-Gonzales A, Alvarez-Sanchez N, Lardone PJ et al (2014) Melatonin treatment improves primary progressive multiple sclerosis: a case report. J Pineal Res 35:1\u20135","journal-title":"J Pineal Res"},{"key":"7_CR78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/jcem-55-1-27","volume":"55","author":"H Iguchi","year":"1982","unstructured":"Iguchi H, Kato KI, Ibayashi H (1982) Age-dependent reduction in serum melatonin concentration in healthy human subjects. JU Clin Endocrinol Metab 55:27\u201329","journal-title":"JU Clin Endocrinol Metab"},{"key":"7_CR79","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-6143.2008.02458.x","volume":"9","author":"BM Tesar","year":"2009","unstructured":"Tesar BM, Du W, Shirali AC et al (2009) Aging augments IL-17 T cell alloimmune responses. Am J Transplant 9:54\u201363","journal-title":"Am J Transplant"},{"key":"7_CR80","first-page":"1","volume":"3","author":"P Lissoni","year":"2020","unstructured":"Lissoni P, Porro G, Rovelli F et al (2020) A review on the potential therapeutic properties of angiotensin 1-7 in most systemic human diseases. Clin Res Hematol 3:1\u20136","journal-title":"Clin Res Hematol"},{"key":"7_CR81","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1073\/pnas.94.21.11704","volume":"94","author":"J Gutkowska","year":"1997","unstructured":"Gutkowska J, Jankowski M, Lampert C et al (1997) Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 94:11704\u201311709","journal-title":"Proc Natl Acad Sci USA"},{"key":"7_CR82","first-page":"149","volume":"57","author":"A Evrard","year":"1999","unstructured":"Evrard A, Hober C, Racadat A et al (1999) Atrial natriuretic hormone and endocrine functions. Ann Biol Clin (Paris) 57:149\u2013155","journal-title":"Ann Biol Clin (Paris)"},{"key":"7_CR83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bjc.6700750","volume":"88","author":"K Grant","year":"2003","unstructured":"Grant K, Loizidou M, Taylor I (2003) Endothelin-1: a multifunctional molecule in cancer. Br J Cancer 88:163\u2013166","journal-title":"Br J Cancer"},{"key":"7_CR84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1051\/jbio:2009005","volume":"203","author":"G Alonso","year":"2009","unstructured":"Alonso G (2009) Vasopressin and angiogenesis. J Soc Biol 203:39\u201347","journal-title":"J Soc Biol"},{"key":"7_CR85","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41577-020-0328-z","volume":"20","author":"O Pacha","year":"2020","unstructured":"Pacha O, Sallman MA, Evans SE (2020) COVID-19: a case for inhibiting IL-17. Nat Rev Immunol 20:345\u2013346","journal-title":"Nat Rev Immunol"},{"key":"7_CR86","doi-asserted-by":"publisher","unstructured":"Ramlall V, Zucker J, Tatonetti N (2020) Melatonin is significantly associated with survival of intubated COVID-19 patients. medRxiv. https:\/\/doi.org\/10.1101\/2020.10.15.20213546","DOI":"10.1101\/2020.10.15.20213546"},{"key":"7_CR87","doi-asserted-by":"crossref","first-page":"13","DOI":"10.29245\/2689-9981\/2020\/1.1155","volume":"3","author":"P Lissoni","year":"2020","unstructured":"Lissoni P, Rovelli F, Monzon A et al (2020) Covid-19 disease as an acute angiotensin 1-7 deficiency: a preliminary phase-2 study with angiotensin 1-7 in association with melatonin and cannabidiol in symptomatic Covid 19-infected subjects. J Infectiol 3:13\u201316","journal-title":"J Infectiol"},{"issue":"2","key":"7_CR88","first-page":"13","volume":"3","author":"P Lissoni","year":"2020","unstructured":"Lissoni P, Rovelli F, Monzon A et al (2020) COVID-19 disease as an acute angiotensin 1-7 deficiency: a preliminary phase 2 study with angiotensin 1-7 in association with melatonin and Cannabidiol in symptomatic COVID-19 -InfectedSubjects. J Infectiol 3(2):13\u201316","journal-title":"J Infectiol"}],"container-title":["Methods in Molecular Biology","Psychoneuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4200-9_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T19:04:43Z","timestamp":1740423883000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4200-9_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"ISBN":["9781071641996","9781071642009"],"references-count":88,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4200-9_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"16 November 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}